Church & Dwight - Q3 2023
November 3, 2023
Transcript
Operator (participant)
Good morning, ladies and gentlemen, and welcome to Church & Dwight's Q3 2023 earnings conference call. Before we begin, I have been asked to remind you that on this call, the company's management may make forward-looking statements regarding, among other things, the company's financial objectives and forecasts. These statements are subject to risks and uncertainties and other factors that are described in detail in the company's SEC filings. I would now like to introduce your host for today's call, Mr. Matt Farrell, President and Chief Executive Officer of Church & Dwight. Please go ahead, sir.
Matt T. Farrell (Chairman, President & CEO)
Okay. Thank you, operator. Good morning, everybody, and thanks for joining us today. I'll begin with a review of Q3 results, and I'll turn the call over to Rick Dierker, our CFO. When Rick is wrapped up, we'll open the call up for questions. So let's begin. Q3 is the fourth consecutive quarter of solid results, beginning with Q4, 2022. Reported revenue was up 10.5%, which exceeded our 8% outlook. Organic revenue grew 4.8%, also exceeding our 4% outlook. It's worthy of note that our global consumer business posted 5.8% organic growth, which exceeded our expectations. Going the other way, our SPD business accounted for one point of negative growth.
Our gross margin expanded 270 basis points, and marketing as a percentage of sales increased 80 basis points to 11.5% of sales. Adjusted EPS was $0.74, which is 8 cents higher than our 66-cent EPS outlook, and that result was driven by higher than expected sales growth and a gross margin expansion. It's important to call out the 2.7% positive volume growth in Q3. It's the first in 8 quarters, and our expectation is that positive volume growth will continue in Q4 to finish out the year. We continue to grow in the online class of trade. 17% of our global sales were purchased online in Q3, compared to 16% in the year ago quarter. Just a few comments on the economy.
Unemployment remains low in the U.S. and in most of our major international markets. Unemployment is a stat that we closely watch regarding the health of the consumer. Household balance sheets are more stretched as savings are lower and credit card debt is higher. Student loan repayments are restarting. Mortgages and auto loans are more costly. Why? Because of higher interest rates, and higher oil may lead to higher gasoline prices. So a higher cost environment leads to trade down as consumers look for the best value, especially in our household categories, and we are well positioned for this trade down, given that 40% of our portfolio is value products. Now, I'm going to comment on each business. First up is the U.S. The U.S. consumer business posted strong 5.5% organic sales growth, of which 3.6% was volume driven.
Seven of our 14 power brands held or gained market share in the quarter, and for context, the brands that grew share represent 65% of our U.S. sales. Private label is another stat that we closely watch. The good news here is the weighted average private label market share in our categories is stable. Now I want to look at a few of the more important categories in the U.S., starting with laundry. ARM & HAMMER Liquid Laundry continues to see consumption growth driven in part by the continued trade down to value brands and by media support behind our new Give It The Hammer advertising campaign, which celebrates the great value that ARM & HAMMER offers in tough economic times. ARM & HAMMER Liquid Laundry Detergent held share in the quarter as the category grew 5%.
We're now at 14.3% share and XTRA, our extreme value offering, grew consumption 6.1% and increased market share to 3.8%. Regarding new products, we launched a new unit dose form of detergent, ARM & HAMMER Power Sheets Laundry Detergent. As the first laundry detergent sheet from a major brand in the U.S., Power Sheets is a convenient new unit dose form of detergent that delivers an entirely new laundry experience. It is mess-free, it's lightweight, and eliminates plastic bottle waste while delivering the trusted ARM & HAMMER, ARM & HAMMER powerful cleaning performance that consumers have come to rely on and love. We launched the product online in August. In September, Power Sheets was the No. 1 laundry detergent item during Amazon's September Prime Day event.
So we're off to a great start with this innovation, which will roll out even more broadly in 2024. Now, litter. ARM & HAMMER Litter also continues to perform extremely well, with 11% growth outpacing the category, which was up 8% and growing share to almost 25%. Consumers continue to choose ARM & HAMMER Litter offerings. We have steady demand for our premium litter offering, which is a black box, but our orange box, in particular, is driving the growth as it offers a great value for the cost-constrained cat owner. Our new ARM & HAMMER Hardball lightweight clumping litter is off to a solid start as distribution expands in the lightweight segment, where we are underrepresented today. Turning now to personal care, BATISTE grew consumption 14% in the quarter as we continue to build dry shampoo awareness and drive household penetration.
The dry shampoo category and BATISTE have room to run as we continue to invest to build awareness and drive trial, especially through sampling. HERO, which was acquired last October, captured the number one market share position in the total acne treatment category. In the acne patch subcategory, Mighty Patch is over 50% share... Retail distribution continues to grow, and we still have room to run as we expand across all classes of trade. The HERO team is doing a spectacular job growing this business. There continues to be a great deal of buzz here at Church & Dwight around the HERO brand and its future growth potential. Similarly, THERABREATH, which was acquired in 2021, is performing extremely well and has been gaining share at a rapid pace.
In Q3, THERABREATH took over the number one share position in the non-alcohol segment with almost a 29% share. Distribution of THERABREATH has more than doubled since the acquisition date, and we expect this brand to be a long-term grower for Church & Dwight. Regarding a couple of businesses that depressed our results last year, WATERPIK continues to stabilize, with Q3 coming in close to plan, similar to Q2. WATERPIK all-channel consumption actually was up slightly in Q3. Turning to gummy vitamins, while VITAFUSION was close to our expectations in the first half, our consumption was down 11% in Q3, partly due to distribution losses at many retailers due to our supply issues in 2022. And our job now is to win back retailer confidence and then regain lapsed consumers. Next up is international.
Our international team is doing a great job delivering organic sales growth of 7.3% in Q3, driven by broad-based growth in most of our subsidiaries and our global markets group. Volume contributed 2.3% of the growth, and this was led by Stérimar nasal hygiene and OxiClean. Both Stérimar and HERO are gaining distribution across our international markets, and we expect more to follow. And finally, specialty products. Organic sales decreased 10%, but this is largely due to one product line called Megalac, which is being hurt by inexpensive imports. Excluding Megalac, the remainder of SPD delivered positive growth of 2%. I'm gonna wrap up by saying we just closed out a strong October, and we expect positive volume growth for a second consecutive quarter in Q4.
We raised our reported sales outlook to reflect the strength of consumer demand for our products while maintaining our full-year EPS outlook. Now, when we are performing well going into the Q4, it's an opportunity to invest in the business. This is a long-standing practice of reinvestment at Church & Dwight and is well understood by our long-term shareholders. We take a long view with respect to the health of the business. Our business model is working, our value offerings are performing well, as are our premium offerings. Innovative new products are contributing to our growth, and we have one of our best new product lineups coming in 2024. Acquisitions are on track, and significant cash generation positions us to continue to add TSR accretive brands to our portfolio.
Now I'm gonna turn it over to Rick to give you some color around Q3 and the full year, and the investments we'll be making in Q4.
Richard A. Dierker (EVP & CFO)
All right, thank you, Matt, and good morning, everybody. We'll start with EPS. Q3 adjusted EPS was at $0.74, down 2.6% to the prior year. As Matt mentioned, the $0.74 was better than our $0.56 outlook, primarily due to higher than expected sales growth and gross margin expansion. Net sales were up 10.5%, and organic sales were up 4.8%. Over half of our organic growth in the quarter was driven by volume. The total consumer business was up 5.8% organically. Our Q3 gross margin was 44.4%, a 270 basis point increase from a year ago, primarily due to improved pricing, volume, productivity, and the impact of the HERO acquisition, net of the impact of higher manufacturing costs. Let me walk you through the Q3 bridge.
Gross margin was made up of the following: positive 140 basis points impact from price volume mix, positive 120 basis points from acquisitions, and a positive 160 basis point impact from productivity, partially offset by a drag of 150 basis points due to inflation. Moving to marketing. Marketing was $27 million, up year-over-year. Marketing expense as a percentage of sales was 11.5% or 80 basis points higher than Q3 of last year. For SG&A, Q3 adjusted SG&A increased 310 basis points year-over-year, primarily due to higher incentive comp from improved business performance, SG&A related to the HERO acquisition and investment spending. Other expense, all in, was $21.8 million, a $2.4 million dollar increase due to higher average interest rates.
For the full year, we now expect other expense of approximately $95 million. For income tax, our effective rate for the quarter was 24.1%, compared to 20.2% in 2022, an increase of 390 basis points, as the prior year rate included the benefit of a non-recurring state tax reduction. We continue to expect the full year rate to be approximately 22%. And now to cash. For the first nine months of 2023, cash from operating activities was $795 million, an increase of $261 million due to higher cash earnings, including the positive impact from recent acquisitions and improvements in working capital. Turning to the full-year outlook, we now expect the full year 2023 reported sales growth to be approximately 9%, up from our previous outlook of 8%.
We continue to expect organic sales growth to be approximately 5%. We now expect full-year reported gross margin to expand 210 basis points, up from 200 basis points. This is an encouraging trend as we continue to move closer to restoring gross margins to pre-COVID levels. We continue to expect a double-digit % increase in gross profit in full year 2023. Looking at inflation, we continue to expect around $120 million of higher manufacturing costs in 2023. This is well below what we have experienced the last couple of years. While many commodity prices remain below prior year levels, resins and oil-based commodities are a bit higher.
We continue to expect full year marketing as a percent of sales to be 11%, and we continue to expect full year SG&A to be higher in both dollars and as a percent of sales compared to 2022. SG&A is expected to be higher than our previous outlook, driven by incremental R&D investments, higher incentive compensation, given our strong performance, and a bad debt reserve related to one specific customer situation. As in past years, when we have strong business performance, we invest for the future. Our investments will focus on driving future growth with higher marketing dollar investment, R&D investment, including clinical studies, and accelerating product registrations in international markets, as well as driving efficiency, including investments in automation and technology. We continue to expect full year adjusted EPS growth to be approximately 6%.
And as a reminder, our EPS guidance includes the step-up of marketing that we've been talking about and higher SG&A. We continue to expect full year cash flow from operations to be approximately $1 billion. Our full-year CapEx plan is now expected to be approximately $230 million as we continue to make capacity investments, and we expect to return to historical levels of CapEx, about 2% of sales by 2025. Moving on to Q4, we have a strong outlook and expect reported sales growth of 5% and approximately 4% for organic, with volume contributing 1% or better. Organic growth rate in Q4 reflects positives from HERO Litter, and THERABREATH, and negatives from not repeating some low-margin laundry promotions.
We expect gross margin expansion, a significant increase year-over-year in both marketing and SG&A, and marketing is expected to be in excess of 14% in Q4. Adjusted EPS is expected to be $0.63 per share, a 2% increase from last year. To summarize, a strong 9 months of the year behind us, we saw the inflection point of volume growth as expected, and we are spending on marketing and investments to build momentum for 2024 and beyond. With that, Matt and I would be happy to take questions.
Operator (participant)
Thank you. Ladies and gentlemen, we will now begin the question-and-answer session. Should you have a question, please press the star followed by the one on your touch tone phone. You will hear a three-tone prompt acknowledging your request. If you are using a speakerphone, please lift the handset before pressing any keys. Your first question comes from Rupesh Parikh from Oppenheimer. Please go ahead.
Rupesh D. Parikh (Managing Director & Senior Analyst, Food, Grocery & Consumer Products)
Good morning, and thanks for taking my question. So just starting with the Specialty Products segment, how are you thinking about the business in the coming quarters? You know, so this quarter, obviously a larger decline. Just want to get a sense if we should see weakness for a few more quarters until you lap the issue that you cited.
Matt T. Farrell (Chairman, President & CEO)
Yeah, it's gonna be, Rupesh, it's gonna be a drag in Q4. So when we when Rick calls a 4% number for organic for Q4, that's net of SPD, it's which kind of reduces the contribution from the consumer business. But. So, yeah, at least one more quarter where we're gonna be down, maybe in Q1 as well.
Richard A. Dierker (EVP & CFO)
Yeah, I think the new nuance, Rupesh, also is when you look at, like, a 4% growth rate in Q4, like, when we talk about investing, many times we talk about SG&A or marketing. Sometimes when we're doing really well, we also look at customer profitability, and we take, you know, we get ahead of it and cull unprofitable or low-profit promotions in some of our businesses, like laundry.
Rupesh D. Parikh (Managing Director & Senior Analyst, Food, Grocery & Consumer Products)
Great. So that's a good segue to my next question. So organic sales growth was maintained for the full year. So it sounds like those lower-margin laundry promotions is what may have limited that organic sales growth increase for the full year. Is that correct, or is there anything else weighing on the lack of organic growth? Yeah.
Matt T. Farrell (Chairman, President & CEO)
That, that's true. You know, last year in the Q4, looking back now, we had a lot of promotions that we thought were not profitable. So we culled them, and so they're not gonna be in place for this Q4, which obviously results in lower volume.
Rupesh D. Parikh (Managing Director & Senior Analyst, Food, Grocery & Consumer Products)
Great. And maybe just a follow-up, just related to that, is there a way to quantify the impact of those, the lack of running those promotions?
Matt T. Farrell (Chairman, President & CEO)
Easier to do that when the quarter is over than do it right now. Now it's more conjecture, but it is, it is a drag.
Rupesh D. Parikh (Managing Director & Senior Analyst, Food, Grocery & Consumer Products)
Okay, great. Thank you. I'll pass it along.
Matt T. Farrell (Chairman, President & CEO)
Yeah. Thanks, Rupesh.
Operator (participant)
Thank you. The next question comes from Bill Chappell from Truist Securities. Please go ahead.
William Chappell (Managing Director, Equity Research)
Thanks. Good morning.
Matt T. Farrell (Chairman, President & CEO)
Bill.
William Chappell (Managing Director, Equity Research)
Hey, can you talk a little bit about kind of where we are for both HERO and TheraBreath in terms of, as we're moving into next year, trying to understand the distribution. Is it where you expect to be, or, you know, do we have tougher comps for both of those businesses in terms of of growth in year two?
Matt T. Farrell (Chairman, President & CEO)
Well, remember, in year one, we'll say it's 2023, when we were gaining distribution throughout the year, so we'll have full year benefit of all the distribution gains in 2024 versus 2023. So, that's a positive. So naturally, the comps are more difficult once you've got it in place, but the demand for the product is surprising us. In fact, the demand has been exceptional wherever we've launched it. The second thing is, we'll be launching HERO in dozens of countries next year through our global markets group. And that'll happen throughout the year, so that's not a January 1 thing, but we see a lot of opportunity there as well.
Now, THERABREATH, you know, THERABREATH was acquired in December of 2021, and they had far more distribution already than HERO did when we acquired THERABREATH. We did expand that in 2022, but I'd say 2023 versus 2022, there's less benefit from distribution gains in comparison to HERO. What's happening is because of the demand for THERABREATH, and the consumer is voting in favor of THERABREATH, what's happening is retailers are willing to give us more shelf space, and we fully expect to get more shelf space when the resets happen in 2024.
Speaker 18
Yeah, Bill, that's the big difference for 2024. In 2023, we got TDPs, we got, you know, renew retailers, new stores. Now it's all about shelf space and expanding that footprint, and that's what's happening.
Matt T. Farrell (Chairman, President & CEO)
Yep.
William Chappell (Managing Director, Equity Research)
Got it. And then second, just kinda trying to understand the spend or the accelerated spend in Q4 to kinda keep your EPS guidance in check. You know, is that more SG&A? 'Cause it does sound like you'll have some... Your benefit on gross margin by just pulling back on some of the promotions. Or is there – is it – will it hit SG&A and gross profit in terms of kind of how you're trying to reinvest in business to keep things going in 2024?
Speaker 18
Yeah, Bill, it's mostly SG&A. It's, you know, some of it's higher incentive comp, but many of it is in the investments we've talked about these last few quarters and just more of that. I think HERO is a good example. As we fast forward product registrations, we're gonna be in, you know, 40, 50 new countries pretty rapidly because we're able to do that. So we think all these investments are great, and they're gonna help us in 2024 and beyond.
William Chappell (Managing Director, Equity Research)
Great. Thanks.
Speaker 18
Okay, Bill.
Operator (participant)
Thank you. The next question comes from Chris Carey at Wells Fargo Securities. Please go ahead.
Christopher Michael Carey (Managing Director, Head of Consumer Staples Equity Research)
Hey, guys.
Speaker 18
Chris.
Christopher Michael Carey (Managing Director, Head of Consumer Staples Equity Research)
One quick follow-up on laundry and then, you know, broader question. The promotions that you're talking about, had that been occurring, you know, over the course of the year, or was that something new that you did because you're responding to the environment, or you saw an opportunity because you're tracking ahead? I'm trying to understand if we're just lapping something or this is a new decision. So apologies if I missed that, but-
Matt T. Farrell (Chairman, President & CEO)
These are promotions that happened in Q4 2022. That didn't happen in Q3 or Q2 2022, so it was isolated to Q4 last year. And the decision to pull back on those is because we can.
Christopher Michael Carey (Managing Director, Head of Consumer Staples Equity Research)
Yeah, okay.
Matt T. Farrell (Chairman, President & CEO)
And besides, like I said earlier, they weren't the best payback. So we said, "You know, this is a good time not to repeat them.
Christopher Michael Carey (Managing Director, Head of Consumer Staples Equity Research)
Okay, that makes sense. I know, you know, we'll get guidance on 2024 next quarter, but you have given kind of high-level thoughts. You know, as I think about this, volumes positive, you still have gross margin momentum behind productivity, inflation is easing. I think you've kinda taken a view on that, and you've rebased in investment spending this year. Is there anything that we should be just thinking about, perhaps less obvious, going into next year? And just maybe any kinda like high-level thoughts about, you know, how you feel about the business and your momentum going to 2024? Thanks.
Matt T. Farrell (Chairman, President & CEO)
Well, well, Chris, we feel great about the business. You see the kinda numbers we just posted in Q3, and you with the gigantic number, you know, 5.8% organic growth for the consumer business. Then when thinking about Q4, we got another 4% organic growth, and that's got a drag from SBD as well, and we expect a second consecutive quarter of volume growth. So, you know, we hope to start stringing these together. We're gonna have volume growth quarter over each quarter for the next 4 or 5 quarters. Gross margin, you're right. There's...
You know, as Rick said, we'll, if we hit the number that's in the box right now, we'll be 150 basis points short of our high water mark for gross margin, which was 45.5 back in 2019. So, you know, we would expect to get more of that back next year. Not all of it, of course, but we expect gross margin expansion. And, you know, one of the good things about this year is we came all the way back with marketing as percentage of sales. You know, last year we were at 10%. We started the year saying, "Hey, let's try to get to 10.5," and then we're all the way to 11%, so, you know, that's behind us now.
So, the other thing I said was, we have one of our best new product pipelines coming in in 2024, and it's pretty broad-based. So, there's a lot of things we feel real great about, and so we're very confident in the strength of the business.
Christopher Michael Carey (Managing Director, Head of Consumer Staples Equity Research)
Okay, thank you.
Operator (participant)
Thank you. The next question comes from Stephen Powers from Deutsche Bank. Please go ahead.
Stephen Robert Powers (Managing Director, Head of U.S. Consumer Staples Equity Research)
Great. Good morning. Thank you.
Matt T. Farrell (Chairman, President & CEO)
Hi, Steve.
Stephen Robert Powers (Managing Director, Head of U.S. Consumer Staples Equity Research)
A question first, just on the Q4 guidance. I guess two questions actually. The first one, maybe my numbers are off, but it feels like, you know, you kinda need to do $0.64 or even $0.65 in the Q4 to get to $3.15, based on what you've done in the first nine months. Just wanna see if I'm missing something in that math. And then, as we talk about that, Rick, you know, in the... Just the gross margin, I think it implies about 200 basis points of gross margin expansion. I don't know if you're able to kinda preview how you think the bridge between price volume and productivity and inflation will kind of balance out in that 200 basis points.
Matt T. Farrell (Chairman, President & CEO)
Yeah, no problem on the first one, Steve, but if you could repeat the second one, it would be helpful. You're breaking up just-
Speaker 18
Sorry. The two—I think it's about 200 basis points of gross margin expansion implied in the Q4.
Matt T. Farrell (Chairman, President & CEO)
... just how you think that's gonna kind of shake out between the benefits of price and volume versus and productivity offset by the lingering inflation?
Richard A. Dierker (EVP & CFO)
Yeah, got it. Okay, well, the first one is on EPS. I know we, we've— If you take a big step back, we've looked at. We typically repurchased shares on a annual basis to offset share creep. We didn't do that this year. We may get ahead of that in 2023 for 2024. So that and rounding will probably get you most of the way to the difference on your EPS for Q4. The second thing on your gross margin bridge questions, I would say, of course, the price component of the price volume mix component of the gross margin bridge comes down a little bit more in Q4, the price piece.
But the volume and mix piece are gonna go up because we used to have acquisition by itself, which was HERO, and that gets blended into kind of the mix of the portfolio. So I would probably say in Q4, a big tailwind from price volume mix. A little bit lower productivity just because it's timing and those projects were choppy. And then, of course, we go backwards a little bit on manufacturing costs and inflation year-over-year. So those are kind of the three pieces to the main three pieces of the gross margin bridge.
Stephen Robert Powers (Managing Director, Head of U.S. Consumer Staples Equity Research)
Okay, that's perfect. And if I could just, I guess this is more, this is not a 24 question, it's more of a philosophical question. So if we go back to 2021, and, you know, coming into 2022, the original expectation was that, you know, Evergreen was on the table. It didn't play out that way, obviously. But as you, as you think about that, you know, if, if we had grown Evergreen in 2022 and 2023, we'd be looking at, you know, $3.50 thereabouts of earnings in 2023, not $3.15. So I guess the, the question is, you know, as we look forward, is, are you guys approaching the future trying to claw back that $0.35 over time?
Or, you know, have we sort of written off 2022, and we're, we're kind of philosophically running, you know, Evergreen from here?
Matt T. Farrell (Chairman, President & CEO)
Well, Steve, I mean, I think everybody, any public company that is with a question like that is gonna say, "Hey, 2022 was..." And it was the last year of a three-year COVID event. In 2023, there were three things that hit us. It was WATERPIK and vitamins, you know, post-COVID, and then Flawless. So the business then gets to rebaseline WATERPIK, vitamins, and Flawless in 2023, and then we kinda grow from there. So I think that's the simplest way to think about it. With three isolated incidents that affected us in 2022, we got our eyes open about that, those businesses. Vitamin has certainly stabilized. Pardon me, WATERPIK has stabilized. Vitamins is still declining, but we have a path back to stabilize that business next year.
Stephen Robert Powers (Managing Director, Head of U.S. Consumer Staples Equity Research)
Yeah. Fair enough. Appreciate it.
Matt T. Farrell (Chairman, President & CEO)
Sure.
Stephen Robert Powers (Managing Director, Head of U.S. Consumer Staples Equity Research)
Thank you very much.
Matt T. Farrell (Chairman, President & CEO)
Yep.
Operator (participant)
Thank you. The next question comes from Dara Mohsenian from Morgan Stanley. Please go ahead.
Dara Warren Mohsenian (Managing Director, Senior Equity Analyst, Household Products & Beverages)
You guys, so can you give us a little bit more of an update on the VITAFUSION business? You obviously mentioned the weak retail sales, and we can see in the scanner data with the distribution losses. Do you have visibility that can snap back going forward in 2024, that you can, in fact, regain shelf space based on your plans, and perhaps that business can return to growth at some point? And maybe just in general, help us understand your plans on that business for 2024.
Matt T. Farrell (Chairman, President & CEO)
Yeah, well, it's kind of a simple problem. We weren't able to supply in 2022, so we got punished by retailers in 2023, losing shelf space, little interest in taking new product launches, et cetera. And so consequently, you lose shelf space, you're gonna lose consumers. So now the whole game is win in the resets in 2024. Which now is, do we have a lot of visibility to that? We have some right now, we'll have more, we talked to everybody in January. But the fight is really to win back more shelf space in 2024. Now, some good news with respect to vitamins, we are the number one gummy vitamin on Amazon, and we have been doing extremely well there this past year.
So that's gonna be a bigger focus for us, going forward as well. But, we do think it's just execution and blocking and tackling, Steve, to get that business on firm footing.
Richard A. Dierker (EVP & CFO)
And meanwhile, we're investing in a big way on marketing to drive awareness, new packaging, to pop on shelf and, you know, displays, all those tactical things that you can do as the momentum will build back.
Dara Warren Mohsenian (Managing Director, Senior Equity Analyst, Household Products & Beverages)
Okay, great. And then you touched on that you think you're well positioned for consumer trade down. Are you actually seeing that? And then maybe also, can you just give us a sense of the promotional environment you're seeing? Obviously, you touched on the laundry issue specifically, but just in general, the promotional environment.
Matt T. Farrell (Chairman, President & CEO)
Yeah, look, the trade down, as I mentioned in my opening remarks, in the litter, you know, class of trade or litter category, we have a black box and an orange box. And a black box is premium, the orange box is value. And so consumers are staying within the franchise, trading down from black box to orange box, and it, it shows in our shares. So our shares are almost like 25% in litter. Your other question was more broadly with respect, oh, let me comment on laundry as well. I mean, laundry has, we've been doing trade down since the beginning, I guess, the middle of 2022, you know, quarter after quarter. And, you know, this past quarter, liquid laundry grew with the category, but XTRA, you see, is started to grow.
That, again, is a sign of the times. You know, it's a deep value laundry detergent. Once again, I think our portfolio was well positioned for a difficult economic environment. Of course, as long as unemployment stays low, people have jobs. We think that it's gonna people are gonna be discerning when they go shopping, but they have money in their pockets to to shop. I think the best value is gonna win. When it comes to the promotional environment, liquid laundry, just to give you some numbers, round numbers. If you looked at the liquid laundry sold on deal in Q1, it was around 32%. In Q2, it was like 33.5, and Q3 was 35%. Liquid laundry has been creeping up during 2023.
So it's around where we expect it to be pre-COVID, so it's coming all the way back. Same is true for unit dose. If you look at unit dose, you know, sequentially, Q2, Q3, 31% sold on deal in Q2, 36% in Q3. Now, litter is a different story. I think it's largely because of the difficulties that one of the competitors has had and has consequently pulled back on promotion. So, the trend for litter Q1, Q2, Q3 is this like a 15% in Q1, 14.5 in Q2, and like 14.2 in Q3. So that kinda give you a sense for the trend. I'd say in vitamins, it sequentially is up, 200 basis points from Q2 to Q3.
There are some competitors that are spending 55% sold on deal. You can't make a lot of money that way, but it definitely does grab volume. But I think yeah, those four categories, liquid laundry, unit dose, litter, vitamins, give you a sense for what's going on in the promotional environment, Steve.
Stephen Robert Powers (Managing Director, Head of U.S. Consumer Staples Equity Research)
Great. That's helpful. Thanks.
Matt T. Farrell (Chairman, President & CEO)
Okay.
Operator (participant)
Thank you. The next question comes from Lauren Lieberman from Barclays. Please go ahead.
Lauren Rae Lieberman (Managing Director, U.S. Cosmetics, Household & Personal Care & Beverages Equity Research Analyst)
Great, thanks. Good morning.
Matt T. Farrell (Chairman, President & CEO)
Lauren.
Lauren Rae Lieberman (Managing Director, U.S. Cosmetics, Household & Personal Care & Beverages Equity Research Analyst)
I have a question about HERO. Hey, so in the past, I think you've talked about, you know, being focused on sort of acne-related categories, you know, with HERO. But we've seen some press that talks about you expanding into retinol and eye cream and balms and stuff. So just curious kind of where you stand on beauty overall, you know, and just, just perspective there, start there.
Matt T. Farrell (Chairman, President & CEO)
Yeah, well, look, our number one objective is to win in acne, and it's on acne patches and also related products to acne, and that's pretty broad. You know, this is a really, really big category, and the opportunity is not plan on launching in dozens of countries in 2024 with HERO. So, you know, we think there's just so much runway, and there still needs to be greater awareness of the patch form, which is another reason why we wanna make sure we don't get too much of our focus outside the patch category. Now, HERO is a fabulous brand. It resonates with consumers of all ages. We definitely do have the right and the permission to go to categories that are adjacent to acne.
Yeah, that could be in our future, but in the near term, the focus is on patches.
Lauren Rae Lieberman (Managing Director, U.S. Cosmetics, Household & Personal Care & Beverages Equity Research Analyst)
Okay, great. And then just sticking with HERO, and maybe my math is wrong, but just with it moving into organic, I guess in mid-October, it looks like it should add, you know, 2-3 points to organic sales growth in the Q4. So I just wanted to make sure that was sort of roughly the right order of magnitude for thinking about this. And then just ask about sort of what that implies for everything else kind of decelerating sequentially. You know, frankly, is it conservatism, or is there something you're seeing, that would support that, you know, modeling that deceleration? Thanks.
Richard A. Dierker (EVP & CFO)
Hey, Lauren, it's Rick. I would say our math does not lead to 2-3 points of organic contribution from HERO. You know, remember, there was a sell-in to new retail distribution in Q4 last year for HERO. So, you know, from a comp perspective, it just doesn't give you that much that you're calculating. I think, you know, overall, we think consumption is still really strong in Q4, and October was off to a great start. I think Matt mentioned it, it was one of our highest shipment months ever in the history of the company. So we feel really good about our momentum right now. And, you know, we've made some choices to discontinue some promotions, and I think that's what kind of the nuance is for folks that they weren't expecting.
Matt T. Farrell (Chairman, President & CEO)
Yeah, and Lauren, it all depends on your perspective. You know, people, depends on the narrative. You know, do you want to look at sequential, you know, Q3 to Q4? Do you want to look year, just year over year and look at comps and say, what was in last year versus this year? But, you know, we have total confidence in where we sit right now with respect to the demand for the products, as evidenced by such a strong October. So, yeah, we think we got a good number for Q4, and, yeah, sometimes people accuse us of being conservative, but, you know, one thing is for sure about Church & Dwight is we take the long view. We don't have short-term thinking.
I think that anybody listening to the call, and certainly our long-term shareholders understand that we're always palms up and try to make sure create understanding for not just you, the analysts, but for our shareholders. And we're really confident, not only in Q4, but in our future.
Lauren Rae Lieberman (Managing Director, U.S. Cosmetics, Household & Personal Care & Beverages Equity Research Analyst)
Okay, great. Thanks so much. I appreciate it.
Matt T. Farrell (Chairman, President & CEO)
All right.
Operator (participant)
Thank you. The next question comes from Anna Lizzul from Bank of America. Please go ahead.
Anna Jeanne Lizzul (VP, Equity Research Analyst, Household, Personal Care & Beauty)
Hi, good morning, and thanks so much for the question. I wanted to ask on the higher marketing and investment spend. I think some of us were expecting you could potentially see a benefit in market share in certain categories like litter from a competitor's disruption, and maybe that would provide some leverage on the investment side. So I was wondering if you could talk more about where you are investing in terms of marketing spend and where you think you need the most support among your categories. Thanks.
Matt T. Farrell (Chairman, President & CEO)
Yeah, you may be referring to so litter. So, you know, there's some help from litter sales wise in Q3, and some of that will continue in Q4. But, there's lots of opportunities to invest when it comes to marketing. There's not just the advertising. Remember, we got some new products we just launched, like the laundry sheets. But, you know, sampling is another avenue for us. You know, we've had remarkable conversion rates on sampling of, say, THERABREATH. You know, I think that also can be true for laundry sheets. There's non-working media as well that we can get after in Q4 to prepare for 2024.
Over in R&D, there's you know, clinical trials you know that we can start earlier than expected for one product in particular that we're looking at. There's just a whole list of things that we can go after. But generally, we're gonna—we're always gonna be supporting the businesses that need the help, so that would be vitamins, for example. But then you want to feed the strong as well, and we got a lot of businesses that are on fire right now. So we'll just pour it on in Q4.
Anna Jeanne Lizzul (VP, Equity Research Analyst, Household, Personal Care & Beauty)
Great. Thanks very much.
Matt T. Farrell (Chairman, President & CEO)
Okay.
Operator (participant)
Thank you. The next question comes from Andrea Teixeira, from JP Morgan. Please go ahead.
Andrea Faria Teixeira (Managing Director, Senior Equity Research Analyst, Consumer Goods)
Thank you. Good morning, everyone. So I wanted to go back to the 4% organic guide for the Q4. I'll take another swing on that one. You said the 50/50 volume mix would be even higher now in the Q4. So it does imply a really much bigger step down in pricing. And I understand that with the discontinuing of some of the nonprofitable promo that you had, that would imply that obviously, obviously, you had pricing realization higher. So I was trying to see what is implied in your guide. And then related to that also in terms of pricing, and then related to that also, how long do you think it's gonna take? Because it seems as if you're starting to lap those, those promos and, and reducing those promos at the trade.
How long do you think this is gonna linger for, another 3 quarters into 2024?
Matt T. Farrell (Chairman, President & CEO)
Okay. Hey, Andrea. So I guess first of all, in my prepared comments, I said, we thought Q4 would be, you know, 1% or better on volume, so not half. And in
Andrea Faria Teixeira (Managing Director, Senior Equity Research Analyst, Consumer Goods)
Mm-hmm.
Matt T. Farrell (Chairman, President & CEO)
in Q3, it was better than half, but in Q4, we think it's 1% or better. And part of that is because of some of the promotional pullback, and discontinuing promotions, like I talked about. We don't think that continues at all into 2024. Those are some discrete promotions we chose to not repeat in Q4. That's the simple story.
Andrea Faria Teixeira (Managing Director, Senior Equity Research Analyst, Consumer Goods)
Mm-hmm. And then any other one of the things, if we step back then strategically, you have always told us, right, you have 40% of your portfolio in value, which implies obviously the 60, the other 60 is somewhere between mid-tier to above. And of course, the consumer is moving down. Is that like what we've been seeing now, is that probably now we're starting to feel it, right? It's like, you know, it's a race to the bottom in the sense that we'd rather not to have, you know, our consumers trade down in general to you as well, because it's like, at the end of the day, you wanna create growth, and you wanna work with your retailers to create growth in the category for innovation.
So I was wondering if you can kind of like, go back to both laundry and litter, because you have on those categories, you go across, and it's great, but in some ways, you also wanna stop that, you know, that movement in the sense that otherwise it's gonna lower the total value of the category. So can you comment a little bit more on those two specific, as well as the other one, which is the vitamin situation? I thought that at this point, you would have lapped a lot of that impact and that retailers would give you back some shelf resets, and if you can comment on that, for shelf resets into spring for vitamins next year.
Richard A. Dierker (EVP & CFO)
Okay. So, I would take that just in two parts, and I'll start with the second one. On vitamins, we kinda just talked about that recently over the last quarter or two. It's gonna take a full twelve months to get back...
... into the shelf position that we want to, and all those tactics we would talk through is what's gonna enable us to do it. So, I know it feels like it's been a long time, but we've only been talking about that relatively, for a short period of time. Your, your second question on trade down, I think Matt and I have been really clear over a long period of time, the company does really well, our brand portfolio does really well in good times and in bad times, and the value brands, of course, do, do better. But even our, what you would call our mid-tier or premium, it depends what category you're in. And most of our, premium brands, like THERABREATH or HERO, are doing as astonishingly, just fantastic.
You know, yeah, we do have some rise of private label in a couple categories, but in general, consumption is strong for the quarter and for October, is what I would say.
Matt T. Farrell (Chairman, President & CEO)
And Andrea, you know, we feel great about the having this sort of portfolio that gives consumers a choice and can trade down. The thing you got to keep in mind, too, is, if you look back at ARM & HAMMER liquid laundry, it has grown share just about every year that I've been here, year after year, in good times and in bad times. So it's not simply... Yeah, it gets accelerated when you have an economic downturn, but what happens is people trade down, they discover the brand, and they stick with it. That's true for ARM & HAMMER laundry.
Now, if you go over to litter, you know, trade down between black box and orange box is great, keeping consumer in the category, and certainly when the economy recovers, you know, people will trade back up to the black box.
Richard A. Dierker (EVP & CFO)
And just, just one comment for everybody as we move forward, because we're starting to get a little tight on time. Let's just try to keep it to one question and maybe one follow-up question.
Operator (participant)
Thank you. The next question comes from Olivia Tong from Raymond James. Please go ahead.
Olivia Tong (Managing Director, Senior Research Analyst, Consumer)
Great, thank you. First on marketing, can you just talk about what is incremental in Q4 versus your prior expectations, you know, what's driving the 14%? Particularly if there's a big change in certain categories, and then your flexibility around that, because, you know, my-- if I remember correctly, Q3, then Q4.
Richard A. Dierker (EVP & CFO)
We always thought it was be weighted more towards Q4. We did have some marketing shift out of Q3 into Q4, largely because of NPD support. Like, even our laundry sheets, we sold out so fast that we wanted to make sure the marketing was turned on when we had the supply. So we shifted some of that into Q4.
Olivia Tong (Managing Director, Senior Research Analyst, Consumer)
Got it. And then just laundry. Can you talk about, you know, the shape of your laundry portfolio? Because you're, you're first to market with the sheets, which is obviously a premium price product, but then we're cutting back on some promo, but it also sounds like you're benefiting from trade down. So how are you thinking about the positioning of your laundry portfolio, you know, premium versus mid-tier versus sort of the opening price point with XTRA? How do you think about that longer term, and then also just in the midterm as you embark on this next new category?
Matt T. Farrell (Chairman, President & CEO)
Well, if you look at the value detergent, there's value and there's extreme value. So you're right, XTRA is the extreme value, and ARM & HAMMER is the high end of value, maybe even at the low end of mid-tier, and that has been a strategy for a long time. Pods is an area where we're underrepresented, and we only have a 4% share of pods, when in fact, in liquid laundry, we have a 15% share. Now, you know, pods is unit dose, but since so is sheets, and sheets has an advantage in that it's more sustainable, no more plastic jugs. So we do think that that's gonna help us gaining greater share in unit dose.
Yeah, it could cannibalize some ARM & HAMMER pods, but we do think it's gonna be attractive to anybody who's using pods today because we don't have the plastic pouches. This comes in a carton, and people who don't wanna be carrying the big jugs anymore will migrate to sheets as well. So, we think there are a lot of positives by adding sheets to the portfolio.
Olivia Tong (Managing Director, Senior Research Analyst, Consumer)
Got it. Thank you.
Operator (participant)
Thank you. The next question comes from Peter Grom at UBS. Please go ahead.
Peter K. Grom (Equity Research Analyst, Consumer Goods)
Thanks, operator, and good morning, everyone. So I wanted to ask specifically about gross margins. You made a lot of progress this year, and Matt, you kind of mentioned that you saw this opportunity to kind of get back to this 45.5% target. But you also said, I think in your response to Chris's question, that you wouldn't get it all back next year. So can you maybe help us unpack the reasons why that might be the case, just given the momentum you're ending the year with? And then just, you know, maybe building on that, Rick, last year, you kind of mentioned that you were less hedged heading into the year than previously.
Can you maybe just give us, you know, a comment or so on your outlook for inflation and whether or not you're kind of deploying a similar hedging strategy looking ahead? Thanks.
Richard A. Dierker (EVP & CFO)
Yeah, I know this is a lot to do with our forward-looking guidance for 2024. So I would just tell you, we'll get into all those details in January, February. We do think we're going to have gross margin expansion. We think there's tailwinds on gross margin, 'cause for the first time in a long time, productivity can outpace inflation. Inflation, we think, still higher than normal next year, but not anywhere near what it's been like these past few years. So that's kind of what I would tell you in a heartbeat. You know, the other nuance is, you know, really, when we look ahead, our pre-COVID margin should be higher because we have some better, faster-growing personal care products like HERO and THERABREATH. So we fully recognize that as well.
But it's gonna be, like I said, in the Deutsche Bank conference and Barclays conference as well. It's gonna be, you know, 2-3 years to get there. And so we're gonna take a good step each and every year.
Peter K. Grom (Equity Research Analyst, Consumer Goods)
... Thanks so much. I'll pass it on.
Operator (participant)
Thank you. Next question comes from Nick Modi from RBC Capital Markets. Please go ahead.
Nik Modi (Managing Director, Equity Research Analyst, Consumer Staples)
Thanks. Good morning, everyone. Guys, can you just talk about what you're seeing in the M&A environment? You know, as kind of the situation continues to evolve, are you seeing any potential assets out there, brands that might look interesting? And then I have just a follow-up question on the promotional situation.
Matt T. Farrell (Chairman, President & CEO)
Okay. Yeah. Hey, Nick, we're always on the hunt, and we to look at the HERO was acquired last October 2022. And you know, we've looked at three other potential acquisitions since then, all of which we passed on. But we're you know, we're always on a hunt. You know, we got quite a strong balance sheet right now, a lot of cash building up, so we've got a bit of a war chest. I would say that the interest rates will obviously affect the bidding process in any one of these acquisitions or auction processes, and obviously we're affected by that as well.
But you do want to buy brands that, you know, long term are going to be able to grow and interest rates, yeah, they may be high for a few years, but they do moderate, from it seems. So you got to take the long view when you're looking at assets. But there's always something to buy, and we, we've been pretty active at looking at what's available. You had a second question, Nick, on promo?
Nik Modi (Managing Director, Equity Research Analyst, Consumer Staples)
Yeah, I mean, usually when you see these kind of unprofitable promos get called, it's usually part of a revenue growth management initiative, you know, a more focused revenue growth management initiative. Over the years, I haven't heard you guys talk too much about revenue growth management, so I'm just curious, is there just a more concerted effort to really focus of that in that area, and that's what's really driving some of these choices for the Q4? Any perspective around that would be helpful.
Matt T. Farrell (Chairman, President & CEO)
Yeah, no, that's a timely question, Nick. So our international business was really first out of the gate on revenue growth management. We have six subsidiaries, and those six subsidiaries have all been linked up regularly to discuss the tactics in improving revenue. You know, it's all the levers between gross and net. More recently, our U.S. business reorganized so that we can adopt more of those practices that our international businesses own, but also link the U.S. into those six international subsidiaries. So, yeah, the whole concept of revenue growth management is taking hold in the company, and that contributes to making decisions about unprofitable promotions.
Nik Modi (Managing Director, Equity Research Analyst, Consumer Staples)
Great. Thanks, Matt.
Matt T. Farrell (Chairman, President & CEO)
Thank you.
Operator (participant)
Thank you. The next question comes from Jason English, from Goldman Sachs. Please go ahead.
Matt T. Farrell (Chairman, President & CEO)
Hey, Jason.
Jason English (Lead Equity Analyst, Consumer Goods)
Hey. Hey, folks. Thanks for slotting me in. So a couple quick questions. In response to Mr. Grom's question, I was surprised to hear you say that you expect inflation next year to be above average. So I guess two questions related to that. First, what's driving it? And second, in context of that, what sort of pricing environment do you expect next year? Would you expect to see positive price growth in your key categories and from you in the domestic market?
Richard A. Dierker (EVP & CFO)
Yeah. Thanks, Jason. It's Rick. I would say, you know, Mr. Grom got me to comment on 2024 a little bit more than we normally would, but, what, what's normal for us in COGS inflation is around 2% of COGS inflation. That's been, been true for many years, 2013 through 2019, and then it went to 8% during the, the, those COVID years, 2020 to 2022, and then in 2023, it was 4%. My belief is it will be lower than what it is this year, for sure, but a little bit higher than, what we've had in the, in the past. And what's driving that is, some of the oil-based and resin-based, commodities, and that's probably the extent I'll go into right now.
The good news, the good news is that our productivity, it's not going to be as apparent because productivity, for the first time in a long time, can actually offset some of these headwinds, and that wasn't the case during the last few years with COVID. In that type of environment, I don't, I don't think that pricing will play a major role, when, when manufacturers can cover a lot of their cost headwinds. And, you know, in other categories and other companies, you know, there's other commodities that are going the other way, and so that's why there's deflation in some commodity categories. So that's the kind of the short answer from our perspective. We have one price increase that we just rolled out.
You heard us talk last quarter about soda ash and baking soda and those cost inputs being up 40%-50%. We did roll out a price increase on baking soda in October, and that's gonna be out in retail, and we don't have further plans to take price, really.
Jason English (Lead Equity Analyst, Consumer Goods)
Okay, that's helpful. And speaking of commodities, I'm on the website for this Megalac product. It looks like a pretty commoditized product, and it sounds like you have a new competitive threat coming in, undercutting you. First time talking about it, so it's- I'm assuming it's new. I'm assuming it's still early inning. So, can you give us some context to assess the risk? Obviously, if everything else was up to, and this drove it down ten, it's big. How big is it? Like, how big was it before this? How big is it this quarter? And how do you plan to deal with that headwind going forward?
Richard A. Dierker (EVP & CFO)
... Yeah, so Megalac has faced low-priced imports for years, even pre-COVID. We were a little protected from that because of how difficult it was to get shipping containers. So the U.S. market was a little bit more protected, and so Megalac did really well during those few years. So once, you know, shipping constraints were lifted, competitors came back in, low-price competitors were there, and we've lost share. You know, this is a very low-profit business, this one SKU, this one product line. So we are looking hard at how to restructure that business. So not a lot to talk about today, but I would just tell you, yes, revenue is down or volatile, but the impact on profits is minimal.
Jason English (Lead Equity Analyst, Consumer Goods)
Okay, that's helpful. I appreciate it. I'll pass it on.
Operator (participant)
Thank you. The next question comes from Jon Anderson from William Blair. Please go ahead.
Jon Andersen (Partner, Equity Research Analyst, Consumer)
Hey, good morning, everyone. Thanks for the question. Just one, give this a shot. It may be too early for you to comment in detail, but you mentioned a couple of times that you have one of the better or best.
Richard A. Dierker (EVP & CFO)
You broke up.
Matt T. Farrell (Chairman, President & CEO)
We lost him.
Richard A. Dierker (EVP & CFO)
Hey, Jon, yeah, if you can hear us, you, you broke up. We'll give it another second too, and then-
Jon Andersen (Partner, Equity Research Analyst, Consumer)
Given kind of the current macro, is the innovation for 2024 likely to be tilted more towards value than premium? And if you can just kind of characterize it a little bit, given Matt's comments, that it's one of the best or better new product lineups that you've had. Thanks.
Matt T. Farrell (Chairman, President & CEO)
Yeah, well, look, it's a logical question, but it's our first week in November, and we're gonna unveil all those new products, end of January, first week of February, when we give our outlook for next year. So it's best to just stay tuned on that one, Jon.
Jon Andersen (Partner, Equity Research Analyst, Consumer)
Great. Thanks. Can I squeeze one more in?
Richard A. Dierker (EVP & CFO)
Yeah, sure.
Jon Andersen (Partner, Equity Research Analyst, Consumer)
I was wondering-
Richard A. Dierker (EVP & CFO)
We didn't really, you know, you whiffed on the first one, so, yeah.
Jon Andersen (Partner, Equity Research Analyst, Consumer)
Yeah, exactly.
Richard A. Dierker (EVP & CFO)
Go with the second one.
Jon Andersen (Partner, Equity Research Analyst, Consumer)
Yeah, we'll try again. Just WATERPIK, could you give us a little bit more detail around where that business is versus your plan year to date, and really, more importantly, what your expectations are going forward as you look to 2024? Thanks.
Matt T. Farrell (Chairman, President & CEO)
Well, look, this was a reset year for WATERPIK. You know, the whole idea was to get close to plan, try to have a level year when it comes to, when it comes to sales. The business has been struggling because, during COVID, people were pretty flush, people staying home. A lot of water flossers got sold in 2021 and even in some in 2022. So that's where the struggle is in 2023. And then there's always knockoffs that we have to deal with, that we see more and more of those, as well as some private label, which we... It's not a new thing, but it's been more significant in 2023. But that business has been around for decades.
It's the Cadillac when it comes to flossers. We have innovation coming as well for WATERPIK, which we'll talk about at the end of January, first week of February. But innovation and maintaining the brand equity that WATERPIK is the premier water flosser is our strategy going forward.
Operator (participant)
Thank you. The next question comes from Javier Escalante from Evercore ISI. Please go ahead.
Javier Escalante (Senior Managing Director, Equity Research Analyst, Consumer Staples)
Good morning, everyone. My question has to do with volumes. If you can comment what was in the comp versus your growth of around 3%, is there something that is going to anniversary in Q4? And also, if you can give us a sense of underlying category growth in terms of volumes on an all-channel basis and how you stand vis-à-vis that. Thank you.
Richard A. Dierker (EVP & CFO)
Yeah, the first one is similar to what I said with Lauren. You know, there's two things that are kinda impacting the comp in Q4. One is, you know, even for HERO we did have some, you know, big, you know, so that was a higher comp. The second thing was the laundry promotions. We had some discrete laundry promotions and revenue growth management activities that kind of Matt alluded to is what got pared down in Q4 this year. So those are the two things.
Matt T. Farrell (Chairman, President & CEO)
Yeah, and as, as far as, I can't really help you with the, the volumes for our, for our 17 categories, but, what I can, I can tell you is that if, if you look at October and that, we had consumption growth in, in 12 of our 17 categories, so, continues to, sustain what we saw in, in Q3. And remember, Q3 was, you know, half of our growth was driven by volume. We see that to be 1% or better in Q4. But, you know, the good news is that in 12 of our 17 categories, we're seeing growth in, in October, so it's, the beat goes on.
Javier Escalante (Senior Managing Director, Equity Research Analyst, Consumer Staples)
... But you don't have a sense of whether, given the amount of pricing, there has been a pullback in actual usage or purchase frequency?
Matt T. Farrell (Chairman, President & CEO)
No, when you have volume growth, that would suggest that you are seeing consumers migrate to your product. Year-over-year, we have higher, we're shipping more cases and more units. And, like I said, we expect that to continue in Q4.
Javier Escalante (Senior Managing Director, Equity Research Analyst, Consumer Staples)
Okay, thank you.
Operator (participant)
Thank you. The last question comes from Filippo Falorni from Citi. Please go ahead.
Filippo Falorni (VP, Equity Research, Beverages & Household Products)
Hey, good morning, everyone. Keep it quick, thanks. So just a quick question on the marketing expenses percent of sales. You clearly returning to 11%. Should we consider this a new normal for you guys, or in the past, you've also done closer to 12? So just wondering if this is a new normal level of investment. Thank you.
Matt T. Farrell (Chairman, President & CEO)
We've said that 11% is where we wanted to get back to, and we thought it was gonna be a stairstep that would go from 10% in 2022 to 10.5% in 2023 and then 11% in 2024. And we're already now at 11%, and we think that's a good level of spend to sustain and grow our brands.
Filippo Falorni (VP, Equity Research, Beverages & Household Products)
Great. Thank you.
Matt T. Farrell (Chairman, President & CEO)
Okay.
Operator (participant)
Thank you. There are no further questions. I will turn the call back over to Mr. Farrell for closing comments.
Matt T. Farrell (Chairman, President & CEO)
Okay, all right. Hey, thanks for joining us today. We had a great Q3, a lot of momentum going into Q4 and in 2024, and really looking forward to talking to you guys at the end of January or early February with our outlook for 2024. So thanks for joining us today.
Operator (participant)
Ladies and gentlemen, this concludes your conference call for today. We thank you for participating, and we ask that you please disconnect your lines.